SecBot SecBot
SC 13G/A ·Filed Nov 3, 2026
AZ

AZR

Azora Therapeutics, Inc. (DE)
BEARISH
Impact 4/10
Horizondays Processed14d 3h ago SEC0001104659-26-121888
Passive stake amendment
Actionable Insight ▼ Bearish

Monitor for further selling by Coastlands or other insiders; the exit filing removes a passive holder but does not indicate active selling pressure. The stock's high volatility (9.2% normal daily move) means any incremental selling could have outsized price impact.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$4.15
T+0 close · Nov 3, 2026 · via day close
Latest settled
−9.40%
T+5 · $3.76 · next T+20 in 15d
Vs SPY
−8.81%
α at T+5
Latest observation
−2.85%
T+9 · FF3 residual α
  1. T+0 · Nov 3 $4.15entry
  2. T+1 · 13d ago −2.41%α −4.06% · $4.05
  3. T+5 · 7d ago −9.40%α −8.81% · $3.76
  4. T+10 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Coastlands Capital LP filed an exit amendment to its Schedule 13G, reporting it no longer beneficially owns more than 5% of Azora Therapeutics. The filing states the reporting persons hold 655,975 shares (4.99% of 12,878,129 shares outstanding as of Nov 2, 2026), down from a prior above-5% stake. This exit filing signals reduced passive exposure.

Key Financial Metrics

Stake
4.99%
Investor
Coastlands Capital LP
Investor Type
hedge fund

Key Facts

  • Coastlands Capital LP filed Amendment No. 2 to Schedule 13G as an exit filing, stating it no longer beneficially owns more than 5% of Azora Therapeutics.
  • Reporting persons hold 655,975 shares of common stock (including shares issuable upon exercise of pre-funded warrants), representing 4.99% of 12,878,129 shares outstanding as of Nov 2, 2026.
  • The filing was made under Rule 13d-1(b) and Rule 13d-1(c), and the reporting persons certify passive intent.
  • The prior filing (July 2, 2026) showed a stake above 5%; this amendment reflects a reduction below the 5% threshold.

Financial Impact

Stake reduced from above 5% to 4.99% (655,975 shares). No dollar value stated.

ownership_percentage

Risk Factors

  • Exit filing may signal reduced conviction or portfolio rebalancing by Coastlands.
  • Potential further dilution from pre-funded warrants (subject to 4.99% beneficial ownership limitation).

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001104659-26-121888
Document: 0001104659-26-121888-index.html0001104659-26-121888
Document: 0001104659-26-121888.txt0001104659-26-121888

Track record

5 reports on AZR

Performance horizon
Filters
  1. Nov 16, 2026today S-3 Bearish 6/10 Entry $3.81 Now $3.66 +3.81% settles Nov 24
  2. Nov 12, 20265d ago 8-K Neutral 4/10 Entry $4.09 Now $3.66 −10.39% settles Nov 20
  3. Nov 10, 20267d ago 3 Neutral 2/10 Entry $3.76 to $3.67 Now $3.66 −2.53% ▼ −2.53% −0.20% vs SPY
  4. Nov 9, 20268d ago 8-K Neutral 4/10 Entry $3.75 to $3.81 Now $3.66 −2.27% ▲ +1.60% +3.29% vs SPY
  5. Nov 3, 202614d ago SC 13G/A Bearish 4/10 Viewing Entry $4.15 to $3.76 Now $3.66 +11.69% ▲ +9.40% +8.81% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026